Related Experiment Videos
Quinone methide as a new intermediate in eumelanin biosynthesis
1Department of Biology, University of Massachusetts, Boston 02125.
The Journal of Biological Chemistry
|April 5, 1991
Summary
Dopachrome conversion factor catalyzes eumelanin pathway reactions by converting dopachrome to dihydroxyindole. This enzyme
Area of Science:
- Biochemistry
- Melanogenesis Research
- Enzymology
Background:
- Eumelanin biosynthesis involves dopachrome conversion.
- Dopachrome conversion factor (DCF) regulates this key step.
- Understanding DCF mechanism is crucial for melanogenesis research.
Purpose of the Study:
- To elucidate the catalytic mechanism of dopachrome conversion factor.
- To identify the key intermediates in the conversion of dopachrome to dihydroxyindole.
- To determine the substrate specificity of dopachrome conversion factor.
Main Methods:
- Isolation and characterization of dopachrome conversion factor from Manduca sexta.
- Enzymatic assays using various dopachrome derivatives.
- Product identification using spectroscopic methods.
Main Results:
- Dopachrome conversion factor specifically acts on L-isomers, not D-isomers.
- 5,6-dihydroxyindole is the primary product of L-dopachrome conversion.
- Evidence supports a reactive quinone methide intermediate in the reaction.
Conclusions:
- Dopachrome conversion factor facilitates dopachrome aromatization and decarboxylation.
- The enzyme can deprotonate alpha-hydrogen when the carboxyl group is blocked.
- A quinone methide intermediate, not indolenine, is key in dopachrome to dihydroxyindole conversion during melanogenesis.